New Delhi, November 28, 2024 – Apollo Cancer Centres (ACCs), a leader in cutting-edge cancer care, has launched India’s first LungLife Screening Program for early detection of lung cancer. This groundbreaking initiative aims to combat lung cancer, which accounts for 5.9% of all cancers and 8.1% of cancer-related deaths in India. Early detection aids in better treatment outcome and enhances the survival rate.
Dr Nikhil Modi, Senior Consultant – Pulmonology, Apollo Cancer Centre, New Delhi, said, “Lung cancer remains one of the deadliest cancers globally, but early detection notably enhances survival chances. Through our Lung-Life Screening Program, we aim to identify high-risk individuals early, using advanced low-dose CT technology, which minimizes radiation exposure while maximizing diagnostic precision. This program is particularly impactful for individuals with a history of smoking, passive smoking exposure, or a family history of lung cancer. By detecting lung cancer at a treatable stage, we empower patients with better treatment outcomes and build a renewed hope for a healthier future.”
Dr Manish Singhal, Senior Consultant, Medical Oncology, Apollo Cancer Centre, New Delhi, said, “The introduction of Apollo Cancer Centre’s Lung-Life Screening Program marks a pivotal step in addressing the alarming rise of lung cancer in India. With this comprehensive screening program, we focus on early-stage detection, where the chances of effective treatment and recovery are exponentially higher. The program leverages state-of-the-art low-dose CT scans, ensuring accurate diagnoses while prioritizing patient safety. Together, we are not just treating cancer but transforming lives through timely interventions and holistic care tailored to individual needs.”
